KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Income from Continuing Operations: 2018-2025

Historic Income from Continuing Operations for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$27.1 million.

  • Twist Bioscience's Income from Continuing Operations rose 21.79% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.79%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.80% up from last year.
  • As of Q3 2025, Twist Bioscience's Income from Continuing Operations stood at -$27.1 million, which was down 232.97% from $20.4 million recorded in Q2 2025.
  • Twist Bioscience's Income from Continuing Operations' 5-year high stood at $20.4 million during Q2 2025, with a 5-year trough of -$85.6 million in Q2 2024.
  • Its 3-year average for Income from Continuing Operations is -$40.8 million, with a median of -$43.0 million in 2023.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 69.47% in 2021, then skyrocketed by 123.82% in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's Income from Continuing Operations stood at -$45.6 million in 2021, then rose by 8.21% to -$41.8 million in 2022, then decreased by 2.83% to -$43.0 million in 2023, then climbed by 26.53% to -$31.6 million in 2024, then climbed by 21.79% to -$27.1 million in 2025.
  • Its Income from Continuing Operations stands at -$27.1 million for Q3 2025, versus $20.4 million for Q2 2025 and -$39.4 million for Q1 2025.